Cesare Astori
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis.
Journal: Hematological oncology
Published: July 28, 2021
Diagnosis and management of prefibrotic myelofibrosis.
Journal: Expert review of hematology
Published: June 05, 2018
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria.
Journal: Oncotarget
Published: June 07, 2017
Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasms.
Journal: Oncotarget
Published: January 21, 2017
Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.
Journal: Haematologica
Published: August 08, 2015
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene.
Journal: Annals of hematology
Published: March 26, 2015
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
Journal: Blood
Published: July 03, 2014
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
Journal: Blood
Published: December 25, 2013
A novel germline JAK2 mutation in familial myeloproliferative neoplasms.
Journal: American journal of hematology
Published: October 02, 2013
Last Updated: 09/26/2026